下一代测序 (NGS) 市场概览、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPHE100000820
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Next Generation Sequencing Market Size, Opportunities by 2031

Buy Now

下一代测序 (NGS) 市场规模预计将从 2023 年的 100 亿美元增至 2031 年的 347.5 亿美元。预计 2023 年至 2031 年市场复合年增长率为 16.8%。提高吞吐量和降低成本可能仍然是市场的主要趋势。

下一代测序 (NGS) 市场分析

根据 CDC 的数据,每年有 4100 万人死于非传染性疾病 (NCD),相当于全球死亡人数的 74%。在所有非传染性疾病死亡中,77% 发生在低收入和中等收入国家。心血管疾病导致的非传染性疾病死亡人数中,有 1790 万人死亡,其次是癌症(930 万人)、呼吸系统疾病(410 万人)和糖尿病(200 万人)。 测序技术的最新改进使精准医学成为疾病预防、诊断和治疗的模型,特别是用于癌症的治疗。

下一代测序 (NGS) 市场概览

许多公司正在进行支持市场增长的战略发展。例如,2022 年,Illumina 推出了 NovaSeq X 系列,每年生成超过 20,000 个全基因组。同年,Ultima Genomics 推出短读长测序,并推出 100 美元的基因组测序仪。随着此类产品的推出,DNA 测序新类别(称为第三代测序(TGS))目前也正在积极进行中。这些技术可以对单个 DNA 分子进行测序而无需扩增,并且它们允许构建比 NGS 更长的读数。每种技术都可以从 DNA 和 RNA 的单分子中产生长达 15,000 个碱基的超长读数。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

下一代测序 (NGS) 市场:

Next Generation Sequencing (NGS) Market: Strategic Insights

Next Generation Sequencing (NGS) Market
  • CAGR
    CAGR (2023 - 2031)
    16.8%
  • Market Size 2023
    US$ 10.00 Billion
  • Market Size 2031
    US$ 34.75 Billion

Key Players

  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • Qiagen N V
  • Beijing Genomics Institute
  • Perkinelmer Inc
  • F Hoffmann La Roche AG
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd
  • Macrogen Inc

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1产品(平台、服务、消耗品)
    Segment2技术(基因组测序、外显子组测序、重新测序和靶向测序、其他)
      Segment3应用(诊断、药物研发、精准医疗、其他)
        Segment4最终用户(学术及研究机构、制药及生物技术公司、医院及诊所、其他)

          下一代测序(NGS)市场
          • Next Generation Sequencing (NGS) Market
            年均复合增长率(2023 - 2031)
            16.8%
          • 2023 年市场规模
            100 亿美元
          • 2031 年市场规模
            347.5 亿美元

          市场动态

          增长动力
          • 下一代测序 (NGS) 的进步有利于市场
          • 公司战略发展
          未来的趋势
          • 世界卫生组织发布关于使用靶向下一代测序的新指南
          机会
          • 提高吞吐量并降低成本

          关键人物;主力;重要一员

          • 照明公司
          • 赛默飞世尔科技公司
          • 凯杰公司
          • 北京华大基因研究院
          • 珀金内尔默公司
          • F.霍夫曼-拉罗氏股份公司
          • 安捷伦科技
          • 欧陆科技
          • 牛津纳米孔技术有限公司
          • 马克罗根公司

          区域概况

          Next Generation Sequencing (NGS) Market
          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          Next Generation Sequencing (NGS) Market产品
          • 平台
          • 服务
          • 耗材
          Next Generation Sequencing (NGS) Market技术
          • 基因组测序
          • 外显子组测序
          • 重测序和靶向测序
          • 其他
          Next Generation Sequencing (NGS) Market应用
          • 诊断
          • 药物发现
          • 精准医疗
          • 其他
          Next Generation Sequencing (NGS) Market最终用户
          • 学术及研究机构
          • 制药与生物技术公司
          • 医院和诊所
          • 其他的
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          下一代测序 (NGS) 市场驱动因素和机遇

          下一代测序 (NGS) 的进步有利于市场

          新一代测序 (NGS) 带来了基因组学研究的转变,提供了以高通量和经济高效的方式分析DNA 和 RNA分子的无与伦比的能力。这种转变促进了不同领域基因组学的进步。最近的进展致力于降低成本、更快、更准确的测序以及改进的数据分析。这些对于解锁基因组学新见解、提高疾病理解和个性化医疗保健有着巨大的希望。 NGS 的进步对各个研究领域产生了积极影响,包括临床基因组学、传染病、癌症和微生物组研究。

          世界卫生组织发布关于使用靶向下一代测序的新指南

          2024 年 3 月,世界卫生组织 (WHO) 在更新的结核病指南中发布了关于使用新型诊断技术的建议,即用于诊断耐药结核病 (TB) 的靶向 NGS 检测。世界卫生组织还推出了一个新的结核病测序门户,根据新指南提供了超过 56,000 个序列。该门户网站是与 FIND 和 Unitaid 合作开发的,代表着最先进的结核病测序和表型知识库。这将有助于集体了解结核分枝杆菌基因组突变及其与耐药性的关联。

          下一代测序 (NGS) 市场报告细分分析

          促成下一代测序 (NGS) 市场分析的关键部分是产品、技术、应用和最终用户。

          • 根据产品,下一代测序(NGS)市场分为平台、服务和耗材。 2023年,消耗品领域将占据更大的市场份额。
          • 按技术划分,市场分为基因组测序、外显子组测序、重测序和靶向测序等。 2023 年,重测序和靶向测序领域占据最大市场份额。
          • 按应用划分,市场分为诊断、药物发现、精准医疗等。 2023 年,诊断细分市场占据最大市场份额。
          • 就最终用户而言,市场分为学术和研究机构、制药和生物技术公司、医院和诊所等。 2023年,学术和研究机构占据最大的市场份额。

          按地域划分的下一代测序 (NGS) 市场份额分析

          下一代测序(NGS)市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。

          北美市场占据主导地位。在美国,根据美国疾病控制与预防中心 (CDC) 的最新数据,2023 年结核病病例数攀升。 2023 年,病例数较 2022 年增加 16%,达到 9,615 例结核病病例,创历史最高记录自 2013 年以来,每 10 万人中有 2.9 例病例,比 2022 年增加了 15%。政府正在采取措施减少结核病数量。例如,为了到 2035 年解决全球结核病流行问题,世界卫生组织 (WHO) 制定了各种战略。为了与世界卫生组织合作,企业也建立了战略伙伴关系。例如,2022 年 10 月,Illumina Inc. 和 GenoScreen 结成联盟,使全球能够获得结合 Illumina 测序产品的软件包,以检测抗结核药物耐药性并迅速为治疗决策提供信息。预计亚太地区未来几年将以最高的复合年增长率增长。

          下一代测序 (NGS) 市场报告范围

          报告属性细节
          2023年市场规模100亿美元
          2031 年市场规模347.5亿美元
          全球复合年增长率(2023 - 2031)16.8%
          历史数据2021-2022
          预测期2024-2031
          涵盖的细分市场按产品分类
          • 平台
          • 服务
          • 耗材
          按技术
          • 基因组测序
          • 外显子组测序
          • 重测序和靶向测序
          • 其他
          按申请
          • 诊断
          • 药物发现
          • 精准医疗
          • 其他
          按最终用户
          • 学术及研究机构
          • 制药与生物技术公司
          • 医院和诊所
          • 其他的
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          • 照明公司
          • 赛默飞世尔科技公司
          • 凯杰公司
          • 北京华大基因研究院
          • 珀金内尔默公司
          • F.霍夫曼-拉罗氏股份公司
          • 安捷伦科技
          • 欧陆科技
          • 牛津纳米孔技术有限公司
          • 马克罗根公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          下一代测序 (NGS) 市场新闻和最新动态

          下一代测序 (NGS) 市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了下一代测序 (NGS) 市场的一些发展:

          • 根据 Thermo Fisher Scientific 的新闻稿,2022 年 3 月,推出了获得 CE-IVD 标记的 Ion Torrent Genexus Dx 集成测序仪,这是一种下一代测序 (NGS) 平台,只需一天即可提供结果。该系统专为临床实验室设计,经过充分验证,使用户能够在一台仪器上执行诊断测试和临床研究。
          • 2022 年 10 月,Illumina Inc. 发布的新闻稿称,他们已与 GenoScreen 合作,加速全球消灭结核病 (TB) 的进程。该伙伴关系将扩大受结核病影响最严重的国家的能力,以更有效地检测和抗击耐多药结核病(MDR-TB)。

          下一代测序 (NGS) 市场报告范围和交付成果

          《下一代测序(NGS)市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

          • 下一代测序 (NGS) 市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
          • 下一代测序 (NGS) 市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
          • 详细的 PEST/波特五力分析和 SWOT 分析
          • 下一代测序 (NGS) 市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
          • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及下一代测序 (NGS) 市场的最新发展
          • 详细的公司简介

          Next Generation Sequencing (NGS) Market Report Scope

          Report Attribute Details
          Market size in US$ 10.00 Billion
          Market Size by US$ 34.75 Billion
          Global CAGR 16.8%
          Historical Data 2021-2022
          Forecast period 2024-2031
          Segments Covered By 产品(平台、服务、消耗品)
          By 技术(基因组测序、外显子组测序、重新测序和靶向测序、其他)
          By 应用(诊断、药物研发、精准医疗、其他)
          By 最终用户(学术及研究机构、制药及生物技术公司、医院及诊所、其他)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • Illumina Inc
        • Thermo Fisher Scientific Inc
        • Qiagen N V
        • Beijing Genomics Institute
        • Perkinelmer Inc
        • F Hoffmann La Roche AG
        • Agilent Technologies
        • Eurofins Scientific
        • Oxford Nanopore Technologies Ltd
        • Macrogen Inc
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          Which region dominated the Next Generation Sequencing (NGS) market in 2023?

          North America held the largest market for Next Generation Sequencing (NGS). The growth of the region is attributed to continuous rise in the use of Next Generation Sequencing (NGS), innovations in software designs, and increasing awareness among people regarding the benefits for digital healthcare applications.

          What are the driving factors impacting the Next Generation Sequencing (NGS) market?

          The driving factors are increasing adoption of Internet of Things (IoT) & connected devices in healthcare and the advantages offered by Next Generation Sequencing (NGS) (SaMD).

          What are the future trends of the Next Generation Sequencing (NGS) market?

          Increasing number of wearable medical devices is likely to remain key trends in the market.

          Which are the leading players operating in the Next Generation Sequencing (NGS) market?

          S3 Connected Health, BrightInsight, Inc. and CompliancePath are among the top players operating in the Next Generation Sequencing (NGS) market.

          What would be the estimated value of the Next Generation Sequencing (NGS) market by 2031?

          The Next Generation Sequencing (NGS) market size is projected to reach US$ 93.08 billion by 2031.

          What is the expected CAGR of the Next Generation Sequencing (NGS) market?

          The market is expected to register a CAGR of 15.1% during 2023–2031.

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Healthcare IT : READ MORE..